As of November 10, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Hinge Health, Inc. The largest reported stake is Daniel Antonio Perez's, at 15.7%. 28 filings are on record since July 30, 2025 (Schedule 13G/A, February 13, 2026).
Sell to companies like Hinge Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Insight Venture Partners X, LP · Sole voting: 0 · Shared voting: 3,217,008 · Sole dispositive: 0 · Shared dispositive: 3,217,008 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Bessemer Venture Partners X L.P. · Sole voting: 984,511 · Shared voting: 0 · Sole dispositive: 984,511 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: 11.2 Capital I, L.P. · Sole voting: 0 · Shared voting: 1,911,977 · Sole dispositive: 0 · Shared dispositive: 1,911,977 · SCHEDULE 13G/A, 2026-08-13
- · Reporting person: BlackRock, Inc. · Sole voting: 2,928,636 · Shared voting: 0 · Sole dispositive: 2,992,772 · Shared dispositive: 0 · SCHEDULE 13G, 2026-07-28
- · Reporting person: Atomico Advisors IV, Ltd. · Sole voting: 0 · Shared voting: 2,300,000 · Sole dispositive: 0 · Shared dispositive: 2,300,000 · SCHEDULE 13G/A, 2026-06-08
Hinge Health, Inc. has 28 Schedule 13D or 13G filings on record since 2025-07-30. 4 holders' latest filing reports 5% or more of class a common stock, $0.00001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 15.7% | 10,373,350 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 | |
| 13% | 4,025,963 | SCHEDULE 13G, 2025-08-13 | 2025-06-30 | |
| Insight Venture Associates X, L.P. | 9.4% | 6,441,830 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| BlackRock, Inc. | 5.5% | 2,992,772 | SCHEDULE 13G, 2026-07-28 | 2026-06-30 |
| Alyeska Investment Group, L.P. | 4.75% | 1,293,007 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Jane Street Group, LLC | 4.2% | 1,588,611 | SCHEDULE 13G/A, 2026-02-02 | 2025-12-31 |
| 4% | 2,464,657 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 | |
| Deer X & Co. L.P. | 3% | 1,908,707 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Atomico Advisors IV, Ltd. | 2.88% | 2,300,000 | SCHEDULE 13G/A, 2026-06-08 | 2026-04-17 |
| HANSAINVEST Hanseatische Investment-Limited Co | 2.7% | 1,476,600 | SCHEDULE 13G, 2026-04-27 | 2026-03-31 |
| Alkeon Capital Management LLC | 2.1% | 791,104 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Coatue Management, L.L.C. | 0% | 0 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Hinge Health, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Hinge Health, Inc. and the records around it.
Hinge Health, Inc. elsewhere on the record
- Leadership changes Nov 2026
- Who owns it
Companies that share a holder
- Alkeon Capital Management LLC also filed stake reports on 1 other company: Oric Pharmaceuticals, Inc. (Nov 2025)
- HANSAINVEST Hanseatische Investment-Limited Co also filed stake reports on 1 other company: Iris Energy Ltd (Jul 2025)
- Insight Venture Partners X, LP also filed stake reports on 2 other companies: Coursera, Inc. (Aug 2026), Hawkeye 360, Inc. (Aug 2026)
Watch Hinge Health, Inc.
Get an email when Hinge Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Hinge Health, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Hinge Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Hinge Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
35 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Insight Venture Partners X, LP | 0 | 3,217,008 | 0 | 3,217,008 | SCHEDULE 13G/A, 2026-08-14 |
| Insight Venture Partners (Cayman) X, LP | 0 | 2,637,985 | 0 | 2,637,985 | SCHEDULE 13G/A, 2026-08-14 |
| Insight Venture Partners (Delaware) X, LP | 0 | 510,292 | 0 | 510,292 | SCHEDULE 13G/A, 2026-08-14 |
| Insight Venture Partners X (Co-Investors), LP | 0 | 76,545 | 0 | 76,545 | SCHEDULE 13G/A, 2026-08-14 |
| Insight Venture Associates X, L.P. | 0 | 6,441,830 | 0 | 6,441,830 | SCHEDULE 13G/A, 2026-08-14 |
| Insight Venture Associates X, Ltd. | 0 | 6,441,830 | 0 | 6,441,830 | SCHEDULE 13G/A, 2026-08-14 |
| Insight Holdings Group, LLC | 0 | 6,441,830 | 0 | 6,441,830 | SCHEDULE 13G/A, 2026-08-14 |
| BlackRock, Inc. | 2,928,636 | 0 | 2,992,772 | 0 | SCHEDULE 13G, 2026-07-28 |
| 11.2 Capital I, L.P. | 0 | 1,911,977 | 0 | 1,911,977 | SCHEDULE 13G/A, 2026-08-13 |
| 11.2 Capital I Partners, LLC | 0 | 1,911,977 | 0 | 1,911,977 | SCHEDULE 13G/A, 2026-08-13 |
| 11.2 Capital HH, LLC | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| 11.2 Capital IVY, LLC | 0 | 552,680 | 0 | 552,680 | SCHEDULE 13G/A, 2026-08-13 |
| 11.2 Capital Ivy Partners, LLC | 0 | 552,680 | 0 | 552,680 | SCHEDULE 13G/A, 2026-08-13 |
| Qian Zhuang | 0 | 2,464,657 | 0 | 2,464,657 | SCHEDULE 13G/A, 2026-08-13 |
| Bessemer Venture Partners X L.P. | 984,511 | 0 | 984,511 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Bessemer Venture Partners X Institutional L.P. | 924,196 | 0 | 924,196 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Deer X & Co. L.P. | 1,908,707 | 0 | 1,908,707 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Deer X & Co. Ltd. | 1,908,707 | 0 | 1,908,707 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Atomico Advisors IV, Ltd. | 0 | 2,300,000 | 0 | 2,300,000 | SCHEDULE 13G/A, 2026-06-08 |
| Atomico IV, L.P. | 0 | 2,300,000 | 0 | 2,300,000 | SCHEDULE 13G/A, 2026-06-08 |
| Atomico IV (Guernsey), L.P. | 0 | 2,300,000 | 0 | 2,300,000 | SCHEDULE 13G/A, 2026-06-08 |
The latest filing identifies Hinge Health, Inc. by CUSIP 433313103 and gives its principal executive office as 455 Market Street, Suite 700, San Francisco, CA 94105 (SCHEDULE 13G/A, 2026-08-14).
What the percentages are based on
Based on the quotient obtained by dividing (x) the aggregate number of shares of Class A Common Stock and Class B Common Stock beneficially owned by the Reporting Person, by (y) the sum of (i) 62,468,721 shares of Class A Common Stock outstanding as of July 29, 2026, as reported in the Form 10-Q filed on August 6, 2026, and (ii) the number of shares of Class B Common Stock beneficially owned by the Reporting Persons.Insight Venture Associates X, L.P., SCHEDULE 13G/A, 2026-08-14
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the Class A common stock of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.Qian Zhuang, SCHEDULE 13G/A, 2026-08-13
Deer X Ltd- 3.0% DeerX LP - 3.0% BVP X -1.6% BVP X Inst - 1.5% Represents shares of Class A Common Stock of the Issuer underlying shares of Class B Common Stock of the Issuer beneficially owned by the Reporting Persons, which shares of Class B Common Stock are convertible, at the option of the holder, into shares of Class A Common Stock on a 1-for-1 basis.Deer X & Co. L.P., SCHEDULE 13G/A, 2026-08-14
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-30 | Atomico Advisors IV, Ltd. | 8.3% | SCHEDULE 13G |
| 2025-08-13 | Alkeon Capital Management LLC | 5.7% | SCHEDULE 13G |
| 2025-08-13 | Daniel Antonio Perez | 28.2% | SCHEDULE 13G |
| 2025-08-13 | Gabriel M.I. Mecklenburg | 13% | SCHEDULE 13G |
| 2025-08-14 | Insight Venture Associates X, L.P. | 28.8% | SCHEDULE 13G |
| 2025-08-14 | Coatue Management, L.L.C. | 9.9% | SCHEDULE 13G |
| 2025-08-14 | Deer X & Co. L.P. | 13.1% | SCHEDULE 13G |
| 2025-08-14 | Alyeska Investment Group, L.P. | 5.51% | SCHEDULE 13G |
| 2025-08-14 | Qian Zhuang | 12.1% | SCHEDULE 13G |
| 2025-11-14 | Alyeska Investment Group, L.P. | 4.75% | SCHEDULE 13G/A |
| 2025-12-15 | Jane Street Group, LLC | 5.6% | SCHEDULE 13G |
| 2026-01-29 | HANSAINVEST Hanseatische Investment-Limited Co | 5.7% | SCHEDULE 13G |
| 2026-01-30 | The Vanguard Group | 6.87% | SCHEDULE 13G |
| 2026-02-02 | Jane Street Group, LLC | 4.2% | SCHEDULE 13G/A |
| 2026-02-13 | Insight Venture Associates X, L.P. | 19.8% | SCHEDULE 13G/A |
| 2026-02-13 | Alkeon Capital Management LLC | 2.1% | SCHEDULE 13G/A |
| 2026-02-13 | Qian Zhuang | 9.8% | SCHEDULE 13G/A |
| 2026-02-13 | Daniel Antonio Perez | 15.7% | SCHEDULE 13G/A |
| 2026-02-17 | Coatue Management, L.L.C. | 0% | SCHEDULE 13G/A |
| 2026-02-17 | Deer X & Co. L.P. | 8.3% | SCHEDULE 13G/A |
| 2026-03-09 | Atomico Advisors IV, Ltd. | 5.1% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-27 | HANSAINVEST Hanseatische Investment-Limited Co | 2.7% | SCHEDULE 13G |
| 2026-06-08 | Atomico Advisors IV, Ltd. | 2.88% | SCHEDULE 13G/A |
| 2026-07-28 | BlackRock, Inc. | 5.5% | SCHEDULE 13G |
| 2026-08-13 | Qian Zhuang | 4% | SCHEDULE 13G/A |
| 2026-08-14 | Insight Venture Associates X, L.P. | 9.4% | SCHEDULE 13G/A |
| 2026-08-14 | Deer X & Co. L.P. | 3% | SCHEDULE 13G/A |
Questions about who owns Hinge Health, Inc.
Who owns Hinge Health, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Hinge Health, Inc.: Daniel Antonio Perez (15.7%, Schedule 13G/A, filed 2026-02-13), Gabriel M.I. Mecklenburg (13%, Schedule 13G, filed 2025-08-13), Insight Venture Associates X, L.P. (9.4%, Schedule 13G/A, filed 2026-08-14) and BlackRock, Inc. (5.5%, Schedule 13G, filed 2026-07-28).
Who are the largest shareholders of Hinge Health, Inc.?
By the share each holder's latest filing reports, the largest holders of Hinge Health, Inc. on this page are Daniel Antonio Perez (15.7%), Gabriel M.I. Mecklenburg (13%) and Insight Venture Associates X, L.P. (9.4%).
When did Daniel Antonio Perez buy into Hinge Health, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Daniel Antonio Perez on this page is the Schedule 13G, filed 2025-08-13, reporting 28.2%; its latest, Schedule 13G/A filed 2026-02-13, reports 15.7%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 28 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Hinge Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 2, 2026 | Leadership change: James Pursley departs, President, and 2 more | — | Leadership changes | Source |
| May 23, 2025 | IPO filing, Form 424B4 | $32 a share | IPO filings | Source |
| May 16, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| May 13, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| May 5, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| April 7, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| March 10, 2025 | IPO filing, Form S-1 | — | IPO filings | Source |
Tools for this story
Each opens in a new tab, filled in for Hinge Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
